CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market buy 10% owner bought 117,600 shares at $24.86 ($2,923,642)
- 4 Open-market buy 10% owner bought 60,600 shares at an average $24.58 ($1,489,264)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation · Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 3/A Insider 3/A
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice · Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
Page 23 of 25 · 496 filings